Approval · Notice of Compliance 33741 · 2024
DANTRIUM CAPSULES: Notice of Compliance 33741
Issued August 1, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 33741
- Date
- August 1, 2024
- Company
- Endo Operations Ltd.Ballsbridge, Dublin, Ireland
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Administrative: Change in product ownership
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DANTRIUM CAPSULES | 01997602 | Marketed |
Medicinal ingredients
- DANTROLENE SODIUM 25 MG per CAP